REGOXIDINE (FOR WOMEN)
Generic: MINOXIDIL
INNOVUS PHARMACEUTICALSManufacturer
TOPICALRoute
MINOXIDILActive Substance
2024-04-22Original Approval
REGOXIDINE (FOR WOMEN) is FDA application ANDA218616, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
ADVERSE DRUG REACTION
8,573 reports
2
DRUG INEFFECTIVE
6,231 reports
3
APPLICATION SITE PRURITUS
2,536 reports
4
OFF LABEL USE
1,456 reports
5
APPLICATION SITE IRRITATION
1,229 reports
6
APPLICATION SITE PAIN
1,091 reports
7
HEADACHE
1,085 reports
8
ALOPECIA
896 reports
9
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
756 reports
10
APPLICATION SITE DRYNESS
738 reports